Dose Uniformity of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38% Compared with Prednisolone Acetate Ophthalmic Suspension 1%
Sign Up to like & getrecommendations! Published in 2021 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-021-00445-z
Abstract: Introduction Loteprednol etabonate (submicron) ophthalmic gel 0.38% (LE SM gel 0.38%) is a corticosteroid formulation designed to retain the nonsettling characteristics of loteprednol etabonate ophthalmic gel 0.5%, but with reduced drug particle size to improve… read more here.
Keywords: ophthalmic gel; drug; etabonate submicron; loteprednol etabonate ... See more keywords
Development of lipid nanoparticles for transdermal loteprednol etabonate delivery
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Microencapsulation"
DOI: 10.1080/02652048.2022.2079744
Abstract: Abstract Aim Loteprednol etabonate (LE) is a new generation corticosteroid that is used for the treatment of inflammatory and allergic conditions of the eye. Therefore, solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) were… read more here.
Keywords: lipid nanoparticles; nanoparticles transdermal; sln nlc; development lipid ... See more keywords
Cytarabine-Induced Corneal Toxicity: Clinical Features and Relief of Symptoms with Loteprednol Etabonate 0.5% in Two Patients
Sign Up to like & getrecommendations! Published in 2021 at "Turkish Journal of Ophthalmology"
DOI: 10.4274/tjo.galenos.2020.99248
Abstract: We report two patients who developed toxic keratopathy following high-dose cytarabine chemotherapy and whose symptoms resolved following topical loteprednol etabonate 0.5% treatment. A 25-year-old woman and a 26-year-old man with acute myeloid leukemia were referred… read more here.
Keywords: cytarabine induced; corneal toxicity; two patients; induced corneal ... See more keywords